These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3177959)

  • 1. Photoplethysmographic documentation of improved microcirculation after pentoxifylline therapy.
    Roeren T; LeVeen RF; Nugent L
    Angiology; 1988 Nov; 39(11):929-33. PubMed ID: 3177959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intermittent claudication treated with pentoxifylline. A controlled trial].
    Skovborg F; Bonde-Petersen F; Bloch I; Christensen E
    Ugeskr Laeger; 1983 Nov; 145(47):3649-52. PubMed ID: 6362159
    [No Abstract]   [Full Text] [Related]  

  • 3. Acenocoumarol and pentoxifylline in intermittent claudication. A controlled clinical study. The APIC Study Group.
    Dettori AG; Pini M; Moratti A; Paolicelli M; Basevi P; Quintavalla R; Manotti C; Di Lecce C
    Angiology; 1989 Apr; 40(4 Pt 1):237-48. PubMed ID: 2650578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentoxifylline increases extremity blood flow in diabetic atherosclerotic patients.
    Schwartz RW; Logan NM; Johnson PJ; Strodel WE; Fine JG; Kazmers A; Hyde GL
    Arch Surg; 1989 Apr; 124(4):434-7. PubMed ID: 2649042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentoxifylline--a new drug for the treatment of intermittent claudication.
    Chopra HK; Chopra KL; Aggarwal KK; Parashar SK
    Indian Heart J; 1989; 41(2):127-33. PubMed ID: 2744799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled trial of pentoxifylline (Trental 400) in intermittent claudication: clinical, haemostatic and rheological effects.
    Reilly DT; Quinton DN; Barrie WW
    N Z Med J; 1987 Jul; 100(828):445-7. PubMed ID: 3330188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hemorheological, hemocoagulation and photoplethysmographic changes induced by the administration of pentoxifylline in patients with Raynaud's disease].
    Macchione C; Molaschi M; Neirotti M; Garrone MT; Longo F; Pernigotti L
    Minerva Med; 1985 Jul; 76(30-31):1401-5. PubMed ID: 4022431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of pentoxifylline on severe intermittent claudication.
    Reich T; Gillings D
    Angiology; 1987 Sep; 38(9):651-6. PubMed ID: 3310744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of flunarizine and pentoxifylline on walking distance and blood rheology in claudication.
    Perhoniemi V; Salmenkivi K; Sundberg S; Johnsson R; Gordin A
    Angiology; 1984 Jun; 35(6):366-72. PubMed ID: 6375469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentoxifylline in the treatment of intermittent claudication of the lower limbs.
    Reich T; Cutler BC; Lee BY; Porter JM; Reichle FA; Scogin JT; Strandness DE
    Angiology; 1984 Jul; 35(7):389-95. PubMed ID: 6380347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral vasodilators versus pentoxifylline for the treatment of intermittent claudication.
    Aviado DM
    Ric Clin Lab; 1983; 13 Suppl 3():263-8. PubMed ID: 6143383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentoxifylline: a new agent for intermittent claudication.
    Baker DE; Campbell RK
    Drug Intell Clin Pharm; 1985 May; 19(5):345-8. PubMed ID: 3891279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of pentoxifylline on muscle tissue oxygen tension (pO2) of patients with intermittent claudication before and after pedal ergometer exercise.
    Ehrly AM; Saeger-Lorenz K
    Angiology; 1987 Feb; 38(2 Pt 1):93-100. PubMed ID: 3548493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic treatment of intermittent claudication.
    Porter JM; Bauer GM
    Surgery; 1982 Dec; 92(6):966-71. PubMed ID: 7147192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects and limitations of pentoxifylline therapy in various stages of peripheral vascular disease of the lower extremity.
    AbuRahma AF; Woodruff BA
    Am J Surg; 1990 Sep; 160(3):266-70. PubMed ID: 2393054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of claudication with pentoxifylline: are benefits related to improvement in viscosity?
    Johnson WC; Sentissi JM; Baldwin D; Hamilton J; Dion J
    J Vasc Surg; 1987 Sep; 6(3):211-6. PubMed ID: 3625877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentoxifylline treatment of moderate to severe chronic occlusive arterial disease.
    Lee BY; Berkowitz P; Savitsky JP; May GS; Brobst J; McCann WJ
    Clin Cardiol; 1985 Mar; 8(3):161-5. PubMed ID: 3978888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacology of pentoxifylline with special reference to its hemorrheologic effect for the treatment of intermittent claudication.
    Dettelbach HR; Aviado DM
    J Clin Pharmacol; 1985; 25(1):8-26. PubMed ID: 3882773
    [No Abstract]   [Full Text] [Related]  

  • 19. Pentoxifylline: a new drug for the treatment of intermittent claudication. Mechanism of action, pharmacokinetics, clinical efficacy and adverse effects.
    Aviado DM; Porter JM
    Pharmacotherapy; 1984; 4(6):297-307. PubMed ID: 6393073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of response to pentoxifylline therapy in patients with intermittent claudication.
    Thomas JH; Swannack CJ; McAnaw M; Klein S; Kinnaman ML; Iliopoulos JI; Hermreck AS; Pierce GE
    Am J Surg; 1987 Dec; 154(6):663-5. PubMed ID: 3425814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.